Search Results

Filter
  • 1-10 of  190,423 results for ""THALIDOMIDE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Molecular mechanisms of thalidomide effectiveness on COVID-19 patients explained: ACE2 is a new ΔNp63α target gene.

  • Authors : Monteonofrio L; Dipartimento Di Ricerca E Tecnologie Avanzate, Istituto Nazionale Tumori Regina Elena IRCCS, 00144, Rome, Italy.; Virdia I

Subjects: Thalidomide*/Thalidomide*/Thalidomide*/pharmacology ; Thalidomide*/Thalidomide*/Thalidomide*/therapeutic use ; Thalidomide*/Thalidomide*/Thalidomide*/analogs & derivatives

  • Source: Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2024 Nov; Vol. 102 (11), pp. 1371-1380. Date of Electronic Publication: 2024 Sep 18.Publisher: Springer International Country of Publication: Germany NLM ID: 9504370 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Efficacy and Safety of Ixazomib Combined with Thalidomide and Dexamethasone in Treatment of Multiple Myeloma].

  • Authors : Yao XM; Department of Hematology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan Province, China.; Lu ZX

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Dexamethasone*/Dexamethasone*/Dexamethasone*/administration & dosage ; Dexamethasone*/Dexamethasone*/Dexamethasone*/adverse effects

  • Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Oct; Vol. 32 (5), pp. 1450-1454.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

A novel hypothesis about mechanism of thalidomide action on pattern formation.

Subjects: Thalidomide*/Thalidomide*/Thalidomide*/pharmacology ; Epigenesis, Genetic*/Epigenesis, Genetic*/Epigenesis, Genetic*/drug effects ; Indoleacetic Acids*/Indoleacetic Acids*/Indoleacetic Acids*/metabolism

  • Source: Bio Systems [Biosystems] 2024 Dec; Vol. 246, pp. 105344. Date of Electronic Publication: 2024 Sep 26.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 0430773 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of thalidomide in patients with β-thalassemia intermedia and major.

  • Authors : Ju W; Department of Hematology Rheumatology, Zhongshan Boai Hospital, Zhongshan, China.; Din G

Subjects: Thalidomide*/Thalidomide*/Thalidomide*/therapeutic use ; Thalidomide*/Thalidomide*/Thalidomide*/adverse effects ; beta-Thalassemia*/beta-Thalassemia*/beta-Thalassemia*/drug therapy

  • Source: Medicine [Medicine (Baltimore)] 2024 Oct 25; Vol. 103 (43), pp. e40328.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The impact of ageing on the health and wellbeing of people with thalidomide embryopathy: a comparison of the health impact with the general population.

  • Authors : Sagoe K; Health and Wellbeing, Thalidomide Trust, Saint Neots, UK.; Owens WA

Subjects: Thalidomide*/Thalidomide*/Thalidomide*/adverse effects ; Comorbidity* ; Aging*

  • Source: Disability and rehabilitation [Disabil Rehabil] 2024 Oct; Vol. 46 (21), pp. 5029-5037. Date of Electronic Publication: 2024 Feb 06.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9207179 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of thalidomide for recurrent aphthous stomatitis: a systematic review and meta-analysis of randomized controlled trials.

  • Authors : Jian Y; Department of Clinical Pharmacy, The General Hospital of Western Theater Command, Tianhui Road No 270, Chengdu, Sichuan province, China.; Wang F

Subjects: Stomatitis, Aphthous*/Stomatitis, Aphthous*/Stomatitis, Aphthous*/drug therapy ; Thalidomide*/Thalidomide*/Thalidomide*/administration & dosage ; Thalidomide*/Thalidomide*/Thalidomide*/adverse effectsSutton disease 2

  • Source: BMC oral health [BMC Oral Health] 2024 Sep 28; Vol. 24 (1), pp. 1149. Date of Electronic Publication: 2024 Sep 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101088684 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6831

Record details

×
Academic Journal

Thalidomide attenuates radiation-induced apoptosis and pro-inflammatory cytokine secretion in oral epithelial cells by promoting LZTS3 expression.

  • Authors : Liang L; Department of Oncology, The Sixth Affiliated Hospital of Guangxi Medical University, The First People's Hospital of Yulin, Yulin, 537000, Guangxi, China.; Gan M

Subjects: Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Thalidomide*/Thalidomide*/Thalidomide*/pharmacology ; Thalidomide*/Thalidomide*/Thalidomide*/therapeutic use

  • Source: Journal of translational medicine [J Transl Med] 2024 Sep 27; Vol. 22 (1), pp. 863. Date of Electronic Publication: 2024 Sep 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Academic Journal

Lenalidomide or Thalidomide for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma? An Overview of Systematic Reviews.

  • Authors : Visacri MB; Faculty of Pharmaceutical Sciences, University of São Paulo, SP, Brazil. Electronic address: .; Ribeiro MC

Subjects: Lenalidomide*/Lenalidomide*/Lenalidomide*/administration & dosage ; Lenalidomide*/Lenalidomide*/Lenalidomide*/adverse effects ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy

  • Source: Value in health regional issues [Value Health Reg Issues] 2024 Sep; Vol. 43, pp. 100998. Date of Electronic Publication: 2024 May 07.Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII.

  • Authors : Zhao M; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China.

Subjects: Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy ; Piperidines*/Piperidines*/Piperidines*/therapeutic use ; Piperidines*/Piperidines*/Piperidines*/adverse effects

  • Source: Lupus [Lupus] 2024 Sep; Vol. 33 (10), pp. 1109-1115. Date of Electronic Publication: 2024 Aug 08.Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Effect of CAPEOX combined with thalidomide in the treatment of elderly patients with colon cancer: A single-center report.

  • Authors : Zhong N; Department of Oncology, University of South China Affiliated Chenzhou Hospital (Chenzhou First People's Hospital), Chenzhou, Hunan, 423000, China. Electronic address: .; Yu Y

Subjects: Thalidomide*/Thalidomide*/Thalidomide*/administration & dosage ; Thalidomide*/Thalidomide*/Thalidomide*/therapeutic use ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy

  • Source: Asian journal of surgery [Asian J Surg] 2024 Aug; Vol. 47 (8), pp. 3746-3747. Date of Electronic Publication: 2024 May 18.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8900600 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  190,423 results for ""THALIDOMIDE""